Regulation (EU) 2022/641 of the European Parliament and of the Council of 12 April 2022 amending Regulation (EU) No 536/2014 as regards a derogation from certain obligations concerning investigational medicinal products made available in the United Kingdom in respect of Northern Ireland and in Cyprus, Ireland and Malta (Text with EEA relevance)
Basic information
Dates Date of document:
  • April 12, 2022
Date of publication:
  • April 20, 2022
Date of effect:
  • January 31, 2022
    • Application - See Art 2
  • April 20, 2022
    • Entry into force - Date pub. See Art 2
Modified by
Modifies
Modifies:
Affected by case
Legal basis
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE VII - COMMON RULES ON COMPETITION, TAXATION AND APPROXIMATION OF LAWS CHAPTER 3 - APPROXIMATION OF LAWS Article 114 (ex Article 95 TEC)
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE XIV - PUBLIC HEALTH Article 168 (ex Article 152 TEC)
EuroVoc Vocabulary
  • United Kingdom
  • Malta
  • Medicinal products
  • Ireland
  • Internal market - Principles
  • Security of supply
  • Public health
  • Northern Ireland
  • Health protection
  • Medicinal product
  • Import
  • Cyprus
  • Clinical trial
  • Market approval
  • Import licence
  • Proprietary medicinal products